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ABSTRACT : A visual dipstick dot enzyme immunoassay (EIA) for diagnosis
of leprosy is described. The assay is based on detection of IgM antibodies
against phenolic glycolipid (PGL-I) in sera from leprosy patients.The antigen
(PGL-1 or synthetic disaccharide of PGL-I) was dotted on a nitrocellulose pad
stuck on a plastic strip (dipstick).Sera were used at a dilution of 1:200. Per-
oxidase coupled mouse anti-human IgM monoclonal antibodies were used as the
conjugate. A positive test gave a blue dot against a white background. The
test was highly specific for leprosy, and was quite sensitive for detection of bacilli-
ferous (BL/LL) leprosy. The antigen dotted and preblocked dipsticks stored
at room temperature upto 4 months of observation period, were unable in the
assay.
INTRODUCTION
A visual color test which can put in evidence patients or asymptomatic
carriers with high bacillary load would be of utility in leprosy control pro-
gramme. Such, individuals can be deemed to be potential transmitters of
 infection to others in the community and chemotherapy of such cases with
bactericidal drugs can help in containment of the foyer of infection. A
number of immunodiagnostic methods are under development, which in-
clude FLA-ABS test (Abe et al, 1976), radiometric assays (Harboe et al,
1978; Sinha et al, 1983), and enzymeimmunoassays (Brett et al, 1983; Cho
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et al, 1983; Young and Buchanan, 1983; Ralhan et al, 1985). Previous
studies using enzymeimmunoassays (Brett et al, 1983; Cho et al. 1983;
Ralhan et al 1985) have indicated the presence of 1gM class of antibodies in
multi-bacillary (BL/LL) patients against phenohc glycohpid (PGL-I) specific
to M. leprae. ..Most of these assays, except one recently reported (Young
et al, 1985), demand the use of microtitre plates which are not easily available
in leprosy control centres in the country.
We describe here a dipstick visual assay where the colour can serve as a
qualitative test for positive cases.In this immunodot assay, either PGL-I
extracted from armadillo derived M. leprae, or synthetic terminal disacchari-
de linked to bovine serum albumin (Fujiwara et al, 1984) can be used as an
antigen. The test is highly specific for leprosy and patients with active
pulmonary tuberculosis or persons living in endemic areas who are exposed
to a variety ofenvironmental mycobacteria, do not show positivity in the test.
MATERIAL AND METHODS
Materials
Phenolic glycolipid-I was obtained from Dr. P.J. Brennan, Deptt. of
Microbiology, Colorado State University, Colorado, and the WHO IMMLEP.
Synthetic disaccharide (ND-BSA) was provided by Dr. Delphi Chatterjee,
Deptt. of Microbiology, Colorado State University, Colorado. Sera of
patients with leprosy or pulmonary tuberculosis were from Safdarjung
Hospital, New Delhi and Tuberculosis Research Centre, Madras.Microti-
tre plates (Titertek) were from Flow laboratories, USA. Dipsticks with
two pads of nitrocellulose membrane (1 cm X 0.5 cm ; 0.45 µ pore size)
stuck on to a plastic strip (7 cm x 0.5 cm) were made according to our design
by Advanced Microdevices, Ambala, India.Bovine serum albumin (fraction
V), tween-20, 4-Chloro-1-naphthol and o-phenylenediamine, were purchased
from Sigma, USA. Horseradish peroxidase (HRPO) coupled rabbit anti-
mouse immunoglobulins were a product of Dakopatts, Germany.
Methods
Preparation of antibody-enzyme conjugate : Mouse anti-human IgM
monoclonal antibodies were prepared from the ascitic fluid of mice injected
with HB-57 hybridomas obtained from A.T.C.C. lmmunoglobulins were
precipitated with equal volume of saturated ammonium sulphate and dialys-
ed against phosphate buffered saline (PBS; 0.05M, PH 7.4, 150mM NaCl).
The antibodies were conjugated with Horse radish peroxidase using one-step
glutaraldehyde method (Avrameas, 1969).
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Phenolic glycolipids-I : 1 mg of PGL-I dissolved in 5ml of carbobate-
bi buffer, 0.2M, pH 9.6, was sonicated just before use. It was
di e same buffer to give a final concentration of 200 µg/ml for
dipstick dot EIA.
aride (ND-BSA) :3, 6, di-o-methyl glucose-2,
nked to BSA.0.5 ml of lyophilized material con-
sugar (as glucose equivalent) and 200 µg of BSA was recon-
stituted in 0.5 ml of distilled water. It was diluted in carbonate-bicarbonate
buffer, pH 9.6 to a final concentration of 100 ng/ml for plate EIA, and
20 µg/ml for dipstick dot EIA.
Coating of dipstick : The dipstick was rinsed with trisbuffered saline
TBS; 50 mM Tris, 150 mM NaCl, pH 7.4) and dried at room temperature.
 200 ng of PGL-I or 20 ng of ND-BSA, contained in 1 µl of carbonate-bi-
carbonate buffer, pH 9.6, was applied in the centre of the lower piece of
nitrocellulose membrane and dried at room temperature. The upper pad of
nitrocellulose membrane served as internal control. Non-specific binding
sites were blocked with 3% BSA dissolved in TBS for 1 hr at 37°C.
Procedure for dot EIA : The antigen coated preblocked dipstick was
immersed in patient’s serum diluted 1 :200 in TBS-BSA (1%) and incubated
at 37°C for 1 hr.After three washings with TBS, the dipstick was kept for
1 hr at 37°C with 2ml of peroxidase coupled mouse anti-human IgM mono-
clonal antibodies diluted 1 : 500 in TBS-BSA (1%).The dipstick was washed
four times and immersed in substrate solution. Substrate was prepared by
dissolving 4-chloro-1-naphthol (3mg/ml) in anhydrous methanol diluting
1:5 with tris buffer, and adding (1 µl/ml) 30% H2O2. A positive test was
indicated by a blue spot developed within 5 to 10 min against a white
.
Procedure for microtitre plate EIA : Plate EIA with ND-BSA was
performed according to the method described elsewhere (Ralhan et al, 1985)
with some modifications. ND-BSA was used at a concentration of 10ng/
 well and phosphate buffered saline containing 0.1% tween-20 (PBST) was
used. IgM antibodies against ND-BSA were titrated in the assay.
RESULTS
Figure I gives the typical results obtained with the dipstick assay. Sera
from lepromatous leprosy (LL) patients gave a clearly visible. blue coloured
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dot differentiable from the internal reagent control on the upper pad in the
same dipstick.Sera from patients with active pulmonary tuberculosis were
negative in the assay.As antigen, both PGL-I and ND-BSA were usable.
However, ND-BSA gave equal or slightly better colour with the same serum.
A total of 223 sera were analysed by the immunodot and microtitre
plate assays. These included 173 sera from leprosy patients of different
categories,20 normal healthy controls from Delhi, 10 healthy controls from
endemic area (Madras), and 20 sera from patients with active pulmonary
tuberculosis.In each case, the assay was perfomed with both PGL-I and
ND-BSA. The intensity of the colour in the immunodot assay varied from
faint blue to deep blue (Figure 2) which correlated in most cases with the
absorbance in microtitre plate EIA.The dot assay was usually not distinct
for samples giving absorbance below 0.160 for ND-BSA. Figure 3 gives
data on absorbance of all the sera analysed in microtitre plate EIA using
ND-BSA as the antigen.
Shelf life and stability
Dipsticks dotted with ‘antigen and blocked with BSA as described in
methods, were kept at room temperature (20-30°C) and at 4°C and analysed
at 3 weeks interval. Table 1 gives the result on a pooled LL serum,
using the dipsticks stored under the above mentioned conditions.Dipsticks
stored at room temperature upto 112 days of observation period were usable
in the assay without any significant deterioration in the readability.
T ABLE 1 : Shelf life and stability of antigen coated dipsticks.
DAYS STORED 4°C ROOM TEMPERATURE
(20–30°C)
21 + + + + + +
42 + + + + + +
63 + + + + + +
84 + + + + + +
112 + + + + + +
DISCUSSION
Assay for IgM antibodies against the phenolic glycolipid 01 terminal
sugars have both advantages and limitations.Be ng a component unique
to M. leprae, the assay is highly specific and discriminates fully between LL
and tuberculosis patients.The antibodies if present against environmental
188
KUMAR ET AL–DOT ENZYME IMMUNOASSAY FOR DETECTION OF IgM ANTIBODIES
Fig. 1. PGL-I based dipstick dot EIA was highly specific for leprosy.A positive test
with serum from lepromatous leprosy (LL) patient gave a blue dot against
a clear white background of the lower nitrocellulose pad.Th  upper pad served
as the internal reagent control. Sera from patients with active pulmonary
tuberculosis (TB) were negative in the assay.
Fig. 2. The intensity of blue colour of the dot in dipstick assay varied from faint blue
to deep blue (dipsticks 2-5), and it correlated with the gradation ofanti-ND-
BSA antibody (IgM) titres of these sera. Dipstick 1 shows a negative result.
Fig. 3. A microtitrc plate EIA based on synthetic-disaccharide (ND-BSA) was
used for quantitation of IgMantibodies in the sera screcned by dot EIA.
Sera giving absorbance above 0.077 were considered positive in plate
EIA. Most of the sera giving absorbance higher than 0.160 were posi-
tive in dot EIA.
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or other mycobacteria do not interfere in the assay.The m jor limitation
of the assay is its failure to put in evidence treated LL cases in whom the
bacteriological index (BI) may have subsided substantially.A large number
of tuberculoid leprosy patients are also not diagnosed by the assay (Figure
3). This test therefore can be primarily utilized for diagnosis of multibacillary
(BL/LL) leprosy. Microtitre EIA plate technology has been adopted in
many research laboratories.Its main advantage is in furnishing quantita-
tive answers.EIA plates of requisite quality are not yet manufactured in
the country and have to be imported.This factor alongwith the need for
allied technology e.g. multichannel pipettes, plate washer and EIA reader
being not available in most regional and peripheral laboratories, demand
alternative simple approaches.
The present method uses indigenously made dipsticks. Nitrocellulose
paper has good adsorption capacity for the antigen and antigen deposited
is stable at room temperature for four months of observation period.
The dot assay gives visually readable results.With most of the sera
positive by conventional EIA, where absorbance was above 0.160 by ND-
BSA, were positive by dot EIA. Thus except for sera with borderline absor-
bance value in plate EIA, this assay is serviceable.Th  dipstick is easy to
handle. However, further simplification of the procedure may be necessary
for adoption of this technique by the field technician or paramedical worker.
Preliminary results show that the two step incubation method as described
here could be simplified to one step incubation, where conjugate and serum
are added together. It will also be advantageous to employ simpler and
stable substrate.These modifications are in progress.
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